59676-800 : Symtuza Oral Tablet, Film Coated


NDC59676-800
Labeler: Janssen Products Lp
Product Type: Human Prescription Drug
Drug Name:  Symtuza
Dosage Form: Oral Tablet, Film Coated
Application #: NDA210455
Rev. Date: 


NDC Package Codes:

  • 59676-800-30: 30 TABLET, FILM COATED IN 1 BOTTLE (59676‑800‑30)
  • 59676-800-99: 30 TABLET, FILM COATED IN 1 BOTTLE (59676‑800‑99)

Active Ingredients:

  • Darunavir
  • Cobicistat
  • Emtricitabine
  • Tenofovir Alafenamide

Dosage Strength:

  • 800 mg
  • 150 mg
  • 200 mg
  • 10 mg

Pharmaceutical Classes:

  • HIV Protease Inhibitors [MoA]
  • Protease Inhibitor [EPC]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitor [EPC]
  • P-Glycoprotein Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleosides [CS]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 59676-800 QR Code

< Prev: 59676-702Next: 59676-960 >

Related Discussions:

Tenofovir with primolut N
Actually I am taking tenofovir from the past 2 years. Now I need to take primolut N. Can I take it with tenofovir? One o...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 August 2018.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA